ATA165685A - Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate - Google Patents
Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivateInfo
- Publication number
- ATA165685A ATA165685A AT0165685A AT165685A ATA165685A AT A165685 A ATA165685 A AT A165685A AT 0165685 A AT0165685 A AT 0165685A AT 165685 A AT165685 A AT 165685A AT A165685 A ATA165685 A AT A165685A
- Authority
- AT
- Austria
- Prior art keywords
- oxazolidin
- derivatives
- producing new
- producing
- new
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59203624A JPS6183170A (ja) | 1984-09-28 | 1984-09-28 | 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA165685A true ATA165685A (de) | 1990-07-15 |
| AT392069B AT392069B (de) | 1991-01-25 |
Family
ID=16477122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0165685A AT392069B (de) | 1984-09-28 | 1985-05-31 | Verfahren zur herstellung neuer 1,3-oxazolidin-2- on-derivate |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4644063A (de) |
| JP (1) | JPS6183170A (de) |
| KR (1) | KR900004323B1 (de) |
| AR (1) | AR240924A1 (de) |
| AT (1) | AT392069B (de) |
| AU (1) | AU566419B2 (de) |
| BR (1) | BR8502707A (de) |
| CA (1) | CA1252092A (de) |
| CH (1) | CH663207A5 (de) |
| CS (1) | CS273606B2 (de) |
| DE (1) | DE3519261C2 (de) |
| DK (1) | DK165952C (de) |
| ES (2) | ES8800571A1 (de) |
| FR (1) | FR2571052B1 (de) |
| GB (2) | GB8512975D0 (de) |
| HU (1) | HU199132B (de) |
| IN (1) | IN162060B (de) |
| IT (1) | IT1208807B (de) |
| MX (2) | MX161397A (de) |
| MY (1) | MY102081A (de) |
| NL (1) | NL193191C (de) |
| NZ (1) | NZ212143A (de) |
| PH (1) | PH20852A (de) |
| RO (1) | RO91422B (de) |
| SE (1) | SE463100B (de) |
| SU (2) | SU1402263A3 (de) |
| ZA (1) | ZA854001B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6183147A (ja) * | 1984-09-28 | 1986-04-26 | Nippon Chemiphar Co Ltd | 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤 |
| JPH0759570B2 (ja) * | 1986-05-06 | 1995-06-28 | 三井東圧化学株式会社 | ２−オキサゾリジノン類の製造方法 |
| JPH0713017B2 (ja) * | 1986-06-18 | 1995-02-15 | 日本ケミファ株式会社 | 脳細胞保護作用を有する医薬組成物 |
| ES2053748T3 (es) * | 1987-09-10 | 1994-08-01 | Merck Sharp & Dohme | Oxazoles y tiazoles para el tratamiento de la demencia senil. |
| DE68915595T2 (de) * | 1988-03-24 | 1994-09-15 | Sankyo Co | Verwendung von Isoxazolinonen als cerebro-aktive Medikamente. |
| JPH0314562A (ja) * | 1988-04-11 | 1991-01-23 | Nippon Chemiphar Co Ltd | 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤 |
| US5187171A (en) * | 1989-01-09 | 1993-02-16 | G. D. Searle & Co. | Use of a glycine b partial agonist as an antipsychotic |
| DE69320730T2 (de) * | 1992-07-14 | 1999-02-11 | Nippon Chemiphar Co. Ltd., Tokio/Tokyo | Alkylendiaminderivate |
| NZ314207A (en) * | 1992-09-28 | 2000-12-22 | Vertex Pharma | 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers |
| EP0719264B1 (de) * | 1993-09-15 | 1997-12-29 | Merck Sharp & Dohme Ltd. | Imidanolon- und oxanolonderivate als dopaminantagonisten |
| DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| US6037354A (en) * | 1997-06-18 | 2000-03-14 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
| BR112015021940A2 (pt) | 2013-03-14 | 2017-07-18 | Akzo Nobel Chemicals Int Bv | composição agrícola que compreende pelo menos uma substância química agrícola e pelo menos um éter de celulose; método de redução do desvio de pulverização durante a pulverização de uma solução aquosa; e método de aumento da resistência à lavagem pela chuva de uma solução aquosa pulverizada sobre uma superfície |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2437389A (en) * | 1948-03-09 | Oxazoeidones and erocesstok | ||
| DE1135461B (de) * | 1959-05-08 | 1962-08-30 | Knoll Ag | Verfahren zur Herstellung von basisch substituierten Phthalimidinen |
| FR1301267A (fr) * | 1961-04-04 | 1962-08-17 | Science Union Et Compagnie Soc | Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation |
| US3131197A (en) * | 1963-03-13 | 1964-04-28 | Smith Kline French Lab | 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone |
| US3576808A (en) * | 1967-09-15 | 1971-04-27 | Miles Lab | N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones |
| GB1222708A (en) * | 1968-10-22 | 1971-02-17 | Delalande Sa | Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation |
| FR2179582B1 (de) * | 1972-04-13 | 1975-10-10 | Synthelabo |
-
1984
- 1984-09-28 JP JP59203624A patent/JPS6183170A/ja active Granted
-
1985
- 1985-05-21 NZ NZ212143A patent/NZ212143A/en unknown
- 1985-05-22 GB GB858512975A patent/GB8512975D0/en active Pending
- 1985-05-22 SE SE8502525A patent/SE463100B/sv not_active IP Right Cessation
- 1985-05-23 IN IN382/MAS/85A patent/IN162060B/en unknown
- 1985-05-23 DK DK230185A patent/DK165952C/da not_active IP Right Cessation
- 1985-05-24 DE DE3519261A patent/DE3519261C2/de not_active Expired - Fee Related
- 1985-05-24 PH PH32310A patent/PH20852A/en unknown
- 1985-05-27 ES ES543517A patent/ES8800571A1/es not_active Expired
- 1985-05-27 ZA ZA854001A patent/ZA854001B/xx unknown
- 1985-05-28 CA CA000482506A patent/CA1252092A/en not_active Expired
- 1985-05-29 KR KR1019850003726A patent/KR900004323B1/ko not_active Expired
- 1985-05-29 US US06/739,059 patent/US4644063A/en not_active Expired - Lifetime
- 1985-05-30 SU SU853902250A patent/SU1402263A3/ru active
- 1985-05-30 FR FR8508128A patent/FR2571052B1/fr not_active Expired
- 1985-05-30 IT IT8567500A patent/IT1208807B/it active
- 1985-05-30 RO RO118984A patent/RO91422B/ro unknown
- 1985-05-30 GB GB08513685A patent/GB2165237B/en not_active Expired
- 1985-05-30 HU HU852082A patent/HU199132B/hu not_active IP Right Cessation
- 1985-05-31 AR AR300604A patent/AR240924A1/es active
- 1985-05-31 CH CH2317/85A patent/CH663207A5/fr not_active IP Right Cessation
- 1985-05-31 AT AT0165685A patent/AT392069B/de not_active IP Right Cessation
- 1985-05-31 BR BR8502707A patent/BR8502707A/pt not_active IP Right Cessation
- 1985-05-31 CS CS392785A patent/CS273606B2/cs unknown
- 1985-05-31 MX MX205493A patent/MX161397A/es unknown
- 1985-05-31 NL NL8501579A patent/NL193191C/nl not_active IP Right Cessation
- 1985-07-09 AU AU44697/85A patent/AU566419B2/en not_active Ceased
-
1986
- 1986-05-13 SU SU864027452A patent/SU1431679A3/ru active
- 1986-09-18 ES ES557075A patent/ES8802152A1/es not_active Expired
-
1987
- 1987-09-29 MY MYPI87002215A patent/MY102081A/en unknown
-
1990
- 1990-07-16 MX MX2159290A patent/MX21592A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA71183A (de) | Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate | |
| AT384022B (de) | Verfahren zur herstellung von 1,2,4-triazol-3onen | |
| AT389302B (de) | Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate | |
| ATA364384A (de) | Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate | |
| AT382381B (de) | Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate | |
| ATA165685A (de) | Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate | |
| ATA232384A (de) | Verfahren zur herstellung neuer 1,5-benzothiazepine | |
| AT386208B (de) | Verfahren zur herstellung neuer carbapenemzwischenverbindungen | |
| ATA121486A (de) | Verfahren zur herstellung neuer disubstituierter 1,4-piperazinylderivate | |
| AT379144B (de) | Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate | |
| ATA337185A (de) | Verfahren zur herstellung neuer flavolignanderivate | |
| ATA233086A (de) | Verfahren zur herstellung neuer peptidantibiotika | |
| ATA124285A (de) | Verfahren zur herstellung neuer iminothiazolidinderivate | |
| ATA335685A (de) | Verfahren zur herstellung neuer thienopyridinderivate | |
| ATA444982A (de) | Verfahren zur herstellung neuer bisindolalkaloidderivate | |
| ATA310385A (de) | Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate | |
| ATA371584A (de) | Verfahren zur herstellung neuer cephalosporanderivate | |
| ATA172385A (de) | Verfahren zur herstellung neuer naphthoxazine | |
| ATA305785A (de) | Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate | |
| AT385989B (de) | Verfahren zur herstellung neuer derivate des 20,21-dinoreburnamenins | |
| ATA260285A (de) | Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate | |
| ATA215987A (de) | Verfahren zur herstellung neuer chinazolinonverbindungen | |
| AT387576B (de) | Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate | |
| ATA259384A (de) | Verfahren zur herstellung neuer 2,4-dimethyl-2 -hexenderivate | |
| ATA87685A (de) | Verfahren zur herstellung von s- 3morpholino-4- (3'-tert-butylamino-2'-hydroxypropoxy)-1,2,5thiadiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| ELJ | Ceased due to non-payment of the annual fee |